Europ. J. C'a~u'erVol. 14, p. 725. C; Pergamon Press Ltd. 1978. Printed in Great Britain
Announcement N.C.I.-E.O.R.T.C. SYMPOSIUM ON NEW DRUGS IN CANCER THERAPY To be held on 7-8 September, 1978 at the Institut Jules Bordet, Brussels. Chairmen: F. MUGGIAand H. J. TAGNON September 7: E.O.R.T.C. and N.C.I. Investigational Drugs September 8: Adriamycin and Anthracycline Derivatives A small number of free communcations will be integrated in the program. Abstracts must be sent to Dr. M. Rozencweig, Division of Cancer Treatment, National Cancer Institute, Bldg 37, Rm 6A17, Bethesda, Maryland 20014. U.S.A. before 15 July, 1978. Among the participants: P. ALBERTO (Geneva), N. BACHUR (Baltimore), L. BAKER (Detroit),R. BENJAMIN (Houston), G. BONADONNA (Milan), S. K. CARTER (Palo Alto), M. CASAZZA (Milan), H. CORTEs-FuNES (Madrid), J. DANIELS (Stanford), H. DAVIS (Madison), S. GARATTINI (Milan), M. GHIONE (Milan), A GOLDIN (Bethesda), H. HANSEN (Copenhagen), D HENRY (Research Triangle Park), Y. KENIS (Brussels), G. MATH~ (Paris), F. MUGGIA (Bethesda), C. MYERS (Bethesda), C. PRAGA (Milan), M. ROZENCWEIG (Bethesda), M. STAQUET (Brussels), H. TAONON (Brussels), A. TROUET (Brussels), D. VON HOFF (Bethesda). Number of participants will be limited to 200. For details and registration, write to Dr. M. Staquet, E.O.R.T.C. Data Center, Institut Jules Bordet, rue H+ger-Bordet 1, 1000 Bruxelles, Belgium. (Phone: 538.57.90--Telex: 22773). The symposium will be held 2, rue Evers (lst floor), 1000 Bruxelles. Registration fee: 3000 Belgian francs.
THE NETHERLANDS CANCER INSTITUTE (ANTONI VAN LEEUWENHOEK-HUIS) INTERNATIONAL CONFERENCE ON "ENVIRONMENTAL CARCINOGENESIS: OCCURRENCE. RISK EVALUATION AND MECHANISMb OF ACTION OF CHEMICAL CARCINOGENS" On the occasion of the opening of the new Research Laboratory of the Netherlands Cancer Institute an international congress will be held 7-11 May, 1979, at the RAI-Congress Centre in Amsterdam. Some 20 invited speakers will discuss the epidemiology of cancer, occurrence of carcinogens and mechanisms of their action, transplacental carcinogenesis; Host factors as carcinogen metabolism and DNArepair; Modifying factors: dietary components, enzyme inducers, promoters, anticarcinogens; Evaluation of animal experiments and risk assessment of low doses of carcinogen in large populations; Evaluation of short-term assays for identifying chemical carcinogens. At the end of each daily session a period of one hour is reserved for open discussion. For further information, write: Dr. E. Kriek, secretary Organizing Committee, The Netherlands Cancer Institute (Antoni Van Leeuwenhoek-Huis) Plesmanlaan 121, Amsterdam-Slotervaart, The Netherlands.